The FDA’s Center for Biologics Evaluation and Research (CBER) is excited to host a patient and care partner listening meeting – Patient and Care Partner Perspective on Early Enrollment into Gene Therapy Clinical Trials for Rare Diseases on
Wednesday, December 4 from 11:00 a.m.–4:30 p.m. ET.
The objective of this meeting is to understand what patients, and caregivers of patients in the pre-symptomatic or early stages of disease take into consideration when deciding whether to enroll in a gene therapy clinical trial and potentially receive an investigational gene therapy product.
The meeting will be divided into two sessions and patients, advocates, and caregivers are encouraged to request to speak during the registration process. The deadline to request to speak is Tuesday, November 5.
Please join us for this patient-focused event:
Date: December 4, 2024
Time: 11:00 a.m.– 4:30 p.m. ET
Location: This is a virtual public listening meeting and will be held via Zoom.
Registration: This meeting is free and open to the public; however, registration is required. Early registration is recommended. Please register for the event now.
Registration to attend will close on Tuesday, December 3, at 11:59 p.m. ET. A recording and other relevant meeting materials will be posted online following the event. Registration to request to speak or present will close on November 5, at 11:59 p.m. ET.
#clinicaltrials #genetherapy
